Medication info
Seoul Famotidine Tablets 20mg

Seoul Famotidine Tablets 20mg

Prescription medication
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
(Stock Company) Seoul Pharmaceutical
Appearance
White round film-coated tablet
Packaging
500 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 198802643 · Notified 1988.05.11 · Insurance code 652900850

Summary

Main use
Treatment of gastrointestinal disorders (ulcers, gastroesophageal reflux disease, etc.); preanesthetic medication; improvement of gastric mucosal lesions
Who uses it
Adults
Adult dosage
(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults should take 20mg of famotidine per dose twice daily (after breakfast and dinner or at bedtime), or 40mg once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation; switch to oral administration once oral dosing is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, swelling) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Take 10mg of famotidine per dose twice daily (after breakfast and dinner or at bedtime), or 20mg once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve 20mg of famotidine per dose in 20ml of saline or dextrose injection and administer by slow intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week; switch to oral administration once oral dosing is possible. When used as preanesthetic medication, dissolve 20mg in 1-1.5ml of Sterile Water for Injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve it in 20ml of saline or dextrose injection and administer by slow intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
(Stock Company) Seoul Pharmaceutical

Efficacy & effects

Treatment of gastrointestinal disorders (ulcers, gastroesophageal reflux disease, etc.); preanesthetic medication; improvement of gastric mucosal lesions

  • Gastric ulcers
  • duodenal ulcers
  • anastomotic ulcers
  • upper gastrointestinal bleeding
  • acute stress ulcers
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
View approved original text

This medication is primarily used for the treatment of upper gastrointestinal bleeding caused by gastric ulcers, duodenal ulcers, anastomotic ulcers, and acute stress ulcers. It is also effective in treating hemorrhagic gastritis, gastroesophageal reflux disease, and Zollinger-Ellison syndrome, and helps improve lesions such as erosion, bleeding, redness, and swelling of the gastric mucosa during acute exacerbations of acute and chronic gastritis. It is also used as an injection and can be utilized preoperatively. This medication is used to alleviate symptoms and improve lesions related to various gastrointestinal disorders.

Dosage and Administration

Adult dosage

(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults should take 20mg of famotidine per dose twice daily (after breakfast and dinner or at bedtime), or 40mg once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation; switch to oral administration once oral dosing is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, swelling) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Take 10mg of famotidine per dose twice daily (after breakfast and dinner or at bedtime), or 20mg once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve 20mg of famotidine per dose in 20ml of saline or dextrose injection and administer by slow intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week; switch to oral administration once oral dosing is possible. When used as preanesthetic medication, dissolve 20mg in 1-1.5ml of Sterile Water for Injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve it in 20ml of saline or dextrose injection and administer by slow intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used in patients who have had an allergic reaction to any ingredient or similar medications. Caution should be exercised when using this medication in patients with a history of allergies, impaired kidney function, heart disease, weakened liver function, and in elderly patients. This medication can cause severe side effects, so if symptoms such as shock, difficulty breathing, skin rash, blood abnormalities, arrhythmia, liver dysfunction, muscle pain, or changes in consciousness occur during use, the medication should be discontinued immediately and medical attention should be sought. During treatment, the patient's condition should be monitored frequently, and it should be used at the minimum effective dose; if ineffective, alternative treatments should be considered. This medication is taken orally by dissolving it in the mouth, but it should be swallowed with saliva or water to ensure it is not absorbed directly through the oral mucosa. Caution is advised in patients receiving hemodialysis who use this medication with specific phosphate binders, as the effectiveness of the phosphate binder may be diminished. This medication can interact with other drugs, particularly decreasing the effectiveness of antifungal agents or certain anticancer drugs, so all medications being taken should be disclosed to healthcare providers. Elderly patients may have reduced kidney function, allowing the medication to remain in the body longer; therefore, they should use a reduced dose or increased dosing interval with caution. Women who are pregnant or may become pregnant should only use this medication when the benefits outweigh the risks, and nursing mothers should consider discontinuing breastfeeding due to the potential transfer of the drug into breast milk. The safety of this medication in children has not been sufficiently established, so it is advisable to avoid its use in this population. In the case of orally disintegrating tablet formulations, the tablet should be placed on the tongue and dissolved with saliva before swallowing, and it should not be taken lying down without water. Finally, this medication may mask symptoms of stomach cancer, so it should only be used after confirming that it is not cancer.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • systemic flushing
  • angioedema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 90 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • generalized malaise
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • Stevens-Johnson syndrome
  • mucocutaneous syndrome
  • Lyell's syndrome
  • toxic epidermal necrolysis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevated serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • seizures
  • generalized convulsions
  • rigid seizures
  • clonic seizures
  • interstitial nephritis
  • acute renal failure
  • rash
  • exanthema
  • abnormal renal function test results
  • interstitial pneumonia
  • high fever
  • cough
  • dyspnea
  • abnormal chest X-ray
  • heart failure
  • hypersensitivity
  • rash
  • exanthema
  • urticaria
  • erythema
  • facial edema
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • foul-smelling stool
  • thirst
  • nausea
  • vomiting
  • abdominal distention
  • loss of appetite
  • stomatitis
  • hypertension
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • generalized malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • sensory abnormalities
  • heavy feeling in the head
  • reversible confusion
  • depression
  • dizziness
  • irregular menstruation
  • gynecomastia
  • arthralgia
  • elevated CK
  • dysgeusia
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air ingress and should be kept at room temperature away from direct sunlight. Proper storage conditions will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

500 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.